ABBV vs ABT

AbbVie Inc. against Abbott Laboratories — live side-by-side technical comparison.

Prices as of 2026-10-16T20:00:03+00:00 UTC · updates daily

Who leads right now

ABBV leads 4 of the 5 windows we measure — over 1 month ABBV is +8.7% and ABT +2.5%; over year to date ABBV is +24.9% and ABT -16.3%. The ABBV/ABT price ratio stands at 2.7211, above its 50-day average of 2.4873, and above the 200-day average of 2.2952. A ratio above its own average means ABBV is gaining on ABT; on this reading the recent edge belongs to ABBV.

Performance side by side

ABBVABT
Price$285.42 $104.89
1 day +0.7%lead +0.2%
5 days +3.2% +5.3%lead
1 month +8.7%lead +2.5%
6 months +36.6%lead +9.9%
Year to date +24.9%lead -16.3%
52-week position 94% of range 46% of range
52-week range $190.75–$291.40 $81.97–$132.03
vs 50-day average above $262.45 below $105.87
vs 200-day average above $233.95 above $102.81
RSI (14) 71 62
Next earnings 2026-10-302026-10-21

Where each one stands

ABBV — AbbVie Inc.

ABBV trades at $285.42, above its 50-day average of $262.45, and above the 200-day at $233.95. It sits at 94% of its 52-week range ($190.75–$291.40); 14-day RSI is 71, in overbought territory; an average session moves it about 2.4%. For levels, the first level overhead is $300.00 (5.1% away) and the first support below is $275.00 (3.6% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.

ABT — Abbott Laboratories

ABT trades at $104.89, below its 50-day average of $105.87, and above the 200-day at $102.81. It sits at 46% of its 52-week range ($81.97–$132.03); 14-day RSI is 62, in neutral territory; an average session moves it about 2.3%. For levels, the first level overhead is $105.87 (0.9% away) and the first support below is $104.55 (0.3% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.

Which one moves harder

Both move about the same amount day to day (2.4% and 2.3% of price), so the same position size carries comparable risk in either.

What would change the picture

The comparison turns on those levels: ABBV clearing $300.00 or losing $275.00; ABT clearing $105.87 or losing $104.55. Until one of them gives way, the relative reading above stands.

Questions people ask about ABBV vs ABT

Which is performing better right now, ABBV or ABT?
Over the past month ABBV is +8.7% and ABT is +2.5%, so ABBV is ahead on that window. Year to date the figures are +24.9% for ABBV and -16.3% for ABT.
Is ABBV or ABT more volatile?
Both move about the same amount day to day (2.4% and 2.3% of price), so the same position size carries comparable risk in either.
What are the key levels for ABBV and ABT?
ABBV: resistance $300.00, support $275.00; ABT: resistance $105.87, support $104.55. Levels come from recent swing zones and round numbers, recomputed daily.
When do ABBV and ABT report next?
ABBV: 2026-10-30. ABT: 2026-10-21. Earnings reset both the trend and the levels above, so a comparison made today is only good until the next report.
What does the ABBV/ABT ratio mean?
It is simply ABBV's price divided by ABT's — 2.7211 today. When the ratio rises, ABBV is outperforming; when it falls, ABT is. Comparing it to its own 50- and 200-day averages shows whether the current leadership is new or long-standing.

Full technical briefs

ABBV →
AbbVie Inc.
Full technical brief: trend, levels, chart, news
ABT →
Abbott Laboratories
Full technical brief: trend, levels, chart, news

Related comparisons

JNJ vs LLYABBV vs LLYLLY vs UNHLLY vs MRKLLY vs TMOAMGN vs LLYGILD vs LLYABT vs LLY